Taipei, Taiwan

Wei-Hua Chang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wei-Hua Chang: Innovator in Pharmaceutical Compounds

Introduction

Wei-Hua Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic uses. With a total of 4 patents to his name, Chang is recognized for his innovative approaches to treating various medical conditions.

Latest Patents

Chang's latest patents include groundbreaking work on compounds and their pharmaceutical applications. One notable patent describes a compound of Formula (I) or a pharmaceutically acceptable salt thereof, where Ring X is a 3 to 7 membered monocyclic ring. The patent outlines various substituents for the compound, including halogen, OH, and alkyl groups. Additionally, he has developed a method for treating coronavirus infections, which involves administering an effective amount of a composition containing one or more compounds of Formula (I).

Career Highlights

Wei-Hua Chang is currently associated with Syneurx International Corp., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic strategies that address pressing health challenges.

Collaborations

Chang collaborates with esteemed colleagues, including Guochuan Emil Tsai and Yi-Wen Mao, to further enhance the impact of his research. Their combined expertise contributes to the advancement of pharmaceutical sciences.

Conclusion

Wei-Hua Chang stands out as a key figure in the field of pharmaceutical innovation. His contributions through patents and collaborative efforts are paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…